Cold Chain is an essential component in the globalisation of the pharmaceutical supply chain with an increasing focus on managing the cold chain distribution of temperature sensitive products; to ensure quality, efficacy and compliance are maintained. Approximately 10% of the pharmaceuticals sold worldwide are biopharmaceuticals, equating to $41 billion.
Building on SMi's Cold Chain Distribution Portfolio, we are bringing the conference to the US, creating an event that develops your ability to learn and understand how your peers are working within the cold chain distribution field, with case study led presentations and round table discussions, you’re able to benchmark against others to develop an efficient and effective cold chain distribution process with temperature monitoring, mapping and GDP compliance at the forefront of any strategic planning.
This increased investment means the industry is continuously looking to develop and manage a coherent and efficient supply chain to ensure quality distribution of temperature monitored pharmaceutical products. Storage conditions of these shipments must be monitored and mapped during transit to ensure compliance with the principles of Good Distribution Practice (GDP). With changes to the USP Chapter <1083>, a key focus at SMi’s Conference will be understanding the requirements and assess improvements to ensure a sound cold chain distribution process.
Electronic Access - Single User Fulfilled By Publisher
CD-ROM Mail Delivery
Electronic Access - Global site License Fulfilled By Publisher